Anna E. Lokshin

Works at

Sources: reporter.nih.gov

Grants and prizes

  • National Cancer Institute

    R01, Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers, R01CA260399, 2022–2026, 7 May 2026

  • National Cancer Institute

    R01, Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer, R01CA254036, 2021–2027, 28 Feb 2025

  • National Cancer Institute

    R01, Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms, R01CA247220, 2020–2026, 2 May 2024

Sources: reporter.nih.gov